CERO THERAPEUTICS HOLDINGS I (CERO) Stock Balance Sheet
USA - NASDAQ:CERO - US71902K4022 - Common Stock
5.4 USD
-0.03 (-0.55%)
5.4 USD
0 (0%)
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 97.00K | 476.00K | 1.10M | |||
| Cash Equivalents | 5.20M | 3.33M | N/A | N/A | N/A | |||
| Other Current Assets | 564.50K | 387.00K | 8.46M | 41.89M | 263.00K | |||
| Total Current Assets | 5.77M | 3.71M | 8.56M | 42.37M | 1.36M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.72M | 1.99M | N/A | N/A | N/A | |||
| Investments And Advances | N/A | N/A | N/A | 0.00 | 178.50M | |||
| Other Non-Current Assets | 500.00K | 500.00K | N/A | 0.00 | 218.00K | |||
| Total Non-Current Assets | 2.22M | 2.49M | 0.00 | 0.00 | 178.72M | |||
| TOTAL ASSETS | 7.99M | 6.21M | 8.56M | 42.37M | 180.08M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 1.55M | 650.00K | 0.00 | |||
| Accrued Expenses | 1.10M | 2.79M | 56.00K | 0.00 | 80.00K | |||
| Accounts Payable | 6.65M | 4.51M | 3.54M | 1.65M | 14.00K | |||
| Other Current Liabilities | 105.50K | 105.50K | 27.00K | 28.45M | 3.00K | |||
| Total Current Liabilities | 7.86M | 7.40M | 5.17M | 30.75M | 98.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 461.60K | 699.10K | 9.15M | 9.15M | 9.15M | |||
| Total Non-Current Liabilities | 461.60K | 699.10K | 9.15M | 9.15M | 9.15M | |||
| TOTAL LIABILITIES | 8.32M | 8.10M | 14.32M | 39.90M | 9.25M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -76.02M | -70.92M | -14.20M | -10.76M | -7.67M | |||
| Additional Paid In Capital | 73.34M | 67.14M | N/A | 0.00 | 0.00 | |||
| Common Shares | 2.43M | 3.18M | 8.44M | 13.22M | 178.50M | |||
| Other Shareholders' Equity | -78.80K | -1.30M | N/A | N/A | N/A | |||
| Shares Outstanding | 258.50K | 120.80K | 7.50K | 7.50K | 22.98M | |||
| Tangible Book Value per Share | -10.67 | -41.98 | -0.92 | 0.36 | 7.43 | |||
| Total Shareholders' Equity | -329.40K | -1.89M | -5.76M | 2.47M | 170.83M | |||
| TOTAL LIABILITIES AND EQUITY | 7.99M | 6.21M | 8.56M | 42.37M | 180.08M | |||
| Statistics | ||||||||
| Current Ratio | 0.73 | 0.50 | 1.65 | 1.38 | 13.89 | |||
| Return On Assets (ROA) | -178.24% | -178.66% | -29.63% | -1.58% | -0.18% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -27.04% | -0.18% | |||
All data in USD , ROIC based on taxRate of 0.21